Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Liquid Biopsy and Solid Standards: Charting the Path to the Clinical Translation of Cerebrospinal Fluid Biomarkers
Riviere-Cazaux, Cécile , Burns, Terry C. , Burns, Terry C

JCO Precision Oncology | June 26, 2025 | Volume: No volume available | Issue: 9 | Pages: No page available

10.1200/po-25-00360 | PMID 40570260 Get It

A global real-world study assessing total time to adrenalectomy in primary aldosteronism
Ter, Charmaine , Koh, Xuan Han , Tran, Hieu , Araujo‐Castro, Marta , Boillos, Marga González , Gkaniatsa, Eleftheria , Reincke, Martín , Adolf, Christian, Tran, Thang Viet , Nayak, Drishya, Grytaas, Marianne Aardal , Matrozova, Joanna, Sukor, Norlela , Ismail, Farhana, Parasiliti‐Caprino, Mirko , Tsuiki, Mika , Ng, Chee Keng , Katabami, Takuyuki , St‐Jean, Matthieu , Saffari, Seyed Ehsan , Teo, Ada Ee Der , Bancos, Irina , Araujo-Castro, Marta , Gkaniatsa, Eleftheria , Reincke, Martin , Adolf, Christian , Stowasser, Michael , Turcu, Adina F , Sukor, Norlela , Kocjan, Tomaz , Parasiliti-Caprino, Mirko , Baudrand, Rene , Murakami, Masanori , Yang, Jun , Ng, Chrislyn , Katabami, Takuyuki , Naruse, Mitsuhide , St-Jean, Matthieu , Ceccato, Filippo , Saffari, Seyed Ehsan , Puar, Troy H , Bancos, Irina , Bassiony, Mohamed A. A. , Paja, Miguel , Stowasser, Michael , Nayak, Drishya, Grytaas, Marianne Aardal , Turcu, Adina F. , Ismail, Farhana, Kocjan, Tomaž , Baudrand, René , Uslar, Thomas , Murakami, Masanori , Yang, Jun , Ceccato, Filippo

European Journal of Endocrinology | June 26, 2025 | Volume: 193 | Issue: 1 | Pages: 65-75

10.1093/ejendo/lvaf124 | PMID 40570195 Get It

Abstract Background Primary aldosteronism (PA) is a common treatable cause of hypertension. When caused by unilateral adrenal disease, it is potentially curable by adrenalectomy. However, specialized tests and other factors may delay definitive treatment. We assessed the time to adrenalectomy (TTA) for patients worldwide. Methods We conducted an international, multicentre retrospective study involving 39 centres from 15 countries to determine the total time taken from the first presentation to adrenalectomy and the intervals between each stage (screening, confirmatory, subtyping, and adrenalectomy). We included patients with PA who underwent adrenalectomy from January 1, 2018, to October 30, 2022. Post-adrenalectomy outcomes were evaluated using the Primary Aldosteronism Surgery Outcome criteria. We performed multivariable quantile and linear regression to identify characteristics associated with longer TTA. Results We included 861 patients, mean age 49.3 ± 11.1 years, and 44.5% were women. Overall median TTA was 13.5 months, IQR: 6.6-24.5. Median intervals were 0.1 months (screening), 1.0 months (confirmatory), 4.1 months (subtyping), and 4.3 months (adrenalectomy). On multivariable analysis, median TTA was increased by 5.4 months for each additional adrenal vein sampling (AVS) procedure. Other factors associated with longer TTA included adrenalectomy post-COVID-19, younger age, and additional screening tests. Compared with countries with routine AVS, those without AVS had a shorter TTA (6.1 vs 15.1 months, P < .001), but greater likelihood of absent/partial biochemical success post-adrenalectomy (27.4% vs 12.4%, P < .001). Conclusion Primary aldosteronism management is time-consuming worldwide, especially for subtyping tests and adrenalectomy. While omitting AVS reduces overall time, patients are less likely to achieve biochemical cure post-adrenalectomy.
Sexual outcomes following Rezum therapy with and without median lobe resection
Hashemi, Milad Bonakdar , Lozoya, Andres H Guillen, Pinkhasov, Alexandr, Köhler, Tobias , Guillen Lozoya, Andres H, Pinkhasov, Alexandr M

The Journal of Sexual Medicine | June 26, 2025 | Volume: 22 | Issue: 8 | Pages: 1523-1524

10.1093/jsxmed/qdaf151 | PMID 40570545 Get It

Nuclear Medicine Lymphoscintigraphy: Applications and Technical Overview
Basavalingu, Deepashri , Elojeimy, Saeed , Mercer, Megan K. , Itani, Malak , Revels, Jonathan , Blacklock, Lisa C. , Wang, Sherry S. , Kolokythas, Orpheus , Behnia, Fatemeh , Revels, Jonathan W , Zuckier, Lionel S, Wang, Sherry S , Kolokythas, Orpheus , Behnia, Fatemeh , Itani, Malak , Basavalingu, Deepashri , Zuckier, Lionel S.

RadioGraphics | June 26, 2025 | Volume: 45 | Issue: 7 | Pages: No page available

10.1148/rg.240207 | PMID 40569836 Get It

Lymphoscintigraphy, which is commonly used for sentinel lymph node mapping, can help diagnose lymphedema, lymphatic leakage, and lymphatic malformations and provides valuable information for surgical planning and treatment.
Karyotypic clonal fraction predicts adverse outcome in TP53 -mutated myeloid neoplasms: an International TP53 investigators Network (iTiN) study
Pandiri, M, Stengel, Anna , Shao, Haipeng , Velmurugan, S. , Jacob, Anisha, Symes, Emily , Kaur, Amandeep , Rojek, Alexandra E. , Sojitra, Payal , Wiredja, Danica , Chang, Hong , Patil, Esha, Patel, Jay , Patel, Ami B. , Pan, Zenggang , Findley, Anthony, Badar, Talha , Tariq, Hamza , Sallman, David A. , Bell, Robert , Perry, Anamarija M. , Fitzpatrick, Carrie , Pandiri, Madhavi , Zhou, Qianghua , Venkataraman, Girish , Badar, Talha , Rojek, Alexandra E , Zhang, Jingjing , Wang, Peng , Shao, Haipeng, Jacob, Anisha, Menon, Madhu P , Ghosh, Sharmila , Wool, Geoffrey D. , Arber, Daniel A. , Findley, Anthony, Haferlach, Claudia

Journal of Clinical Pathology | June 26, 2025 | Volume: 78 | Issue: 9 | Pages: 629-635

10.1136/jcp-2024-209954 | PMID 40571403 Get It

We investigated the prognostic impact of blast counts, TP53 allelic state determinants (number of hits, del(17p), variant allele frequency, complex karyotype),and a novel karyotypic clonal cell fraction (≤50% clonal cells vs >50% clonal cells (termed ‘CK50’)) in 495 individuals with TP53- mutated ( TP53 MUT ) myeloid neoplasms. Outcome examined was 24-month survival (OS24). The cohort (median age 71) included 29% (144/495) myelodysplastic syndromes (MDS)/MDS-acute myeloid leukaemia (AML) (1%–19% blasts) and 71% (351/495) AML (≥20% blasts), with 18% (81/460) having low CK50. Overall, 83% received front-line hypomethylating agents. Higher blast counts (<20% vs ≥20%) were marginally associated with CK50 (p=0.08). In the OS24 analysis, blast count showed a marginal association with OS24 (HR 1.3 (95% CI 1.0 to 1.6); p=0.07), while CK50 predicted significantly inferior outcomes (HR=1.7 (95% CI 1.2 to 2.3); p=0.002). In a multivariable model including all TP53 allelic state determinants, only CK50 and complex karyotype remained relevant for predicting adverse outcomes.
A curriculum for epilepsy surgery: A report from the Surgical Commission's Epilepsy Surgery Educational Task Force and the Educational Council of the ILAE
Dorfer, Christian , Enslin, Nico , Olivera, Tatiana von Hertwig Fernandes de, Wiebe, Samuel , Alotaibi, Faisal , Ali, Rushna , Englot, Dario J. , Cross, J. Helen , Ali, Rushna P, Dorfer, Christian , Englot, Dario J , Cross, Helen J , Nico Enslin, Johannes M , Muh, Carrie R. , Wang, Xiongfei , Wiebe, Samuel , McKhann, Guy M. , Damisah, Eyiyemisi C. , Singh, Gagandeep , Blümcke, Ingmar , Rydenhag, Bertil , Alonso‐Vanegas, Mario , Cukiert, Arthur

Epileptic Disorders | June 26, 2025 | Volume: 27 | Issue: 5 | Pages: 718-728

10.1002/epd2.70054 | PMID 40569634 Get It

Abstract Objective There is a need to develop a comprehensive, formalized, and globally applicable epilepsy surgery curriculum in order to help standardize the quality of epilepsy surgery practice in the world. Methods The Epilepsy Surgery Educational Task Force of the ILAE developed a competency‐based epilepsy surgery educational curriculum comprised of four domains: Diagnosis, Counseling, Pre‐surgical Work‐up, and Surgical Techniques. To evaluate this educational curriculum, a survey questionnaire consisting of 11 items was sent out for feedback to ILAE and IESS members. The survey questionnaire asked respondents to rate the degree of importance of each competency on a five‐point scale that ranged from “extremely important” to “not at all important” and provided space for free text comments. All competencies that were rated as “slightly important” or “somewhat important” by more than 10% of responders, as well as all free text feedback comments, were fully reviewed, and the final curriculum was adjusted accordingly. Results One hundred and twenty‐two responses ( n = 122) were submitted by the ILAE and IESS communities. Seventy‐one percent (71.9%) of the responses came from neurosurgeons of varied experience and training levels. Ninety‐four percent (94.4%) of responders stated that they “support a curriculum to determine the competency of neurosurgeons participating in the care of people with epilepsy in my country,” and 94.3% confirmed that they “would be interested in taking or would recommend an ILAE course based on these competencies, that would provide an ILAE certificate of completion.” Relevant changes within the curriculum were made based on feedback. Significance The newly developed ILAE comprehensive epilepsy surgery educational curriculum has a high level of support from neurosurgeons and neurologists around the world and shows potential for broad acceptance and implementation.
Association of Semaglutide and NAION Reviewed—Reply
Cai, Cindy X. , Chen, John J. , Chen, John J

JAMA Ophthalmology | June 26, 2025 | Volume: 143 | Issue: 8 | Pages: 717

10.1001/jamaophthalmol.2025.1826 | PMID 40569577 Get It

The Oncogenic Burden of Obesity: Mechanistic Links Between Adiposity and Gastrointestinal Cancers—A Comprehensive Narrative Review
Lee, Felicia, Moore, Jessica L. , Markouli, Mariam , Ghusn, Wissam , Ghusn, Wissam , Moore, Jessica

Biomedicines | June 26, 2025 | Volume: 13 | Issue: 7 | Pages: 1571

10.3390/biomedicines13071571 | PMID 40722646 Get It

Obesity is a global health crisis with profound implications for cancer risk, particularly within the gastrointestinal (GI) tract. Mounting evidence demonstrates that excess adiposity contributes to the initiation, progression, and poor outcomes of GI malignancies through a constellation of interrelated mechanisms. This review comprehensively examines the biologic pathways linking obesity to cancers of the esophagus, stomach, colon, liver, pancreas, and gallbladder. Chronic low-grade inflammation, driven by adipose tissue-derived cytokines and immune cell infiltration, plays a central role in tumorigenesis via the activation of NF-κB, STAT3, and other pro-oncogenic signaling cascades. Hyperinsulinemia and insulin resistance increase mitogenic IGF-1 signaling, while dysregulated adipokines, particularly elevated leptin and reduced adiponectin, promote cellular proliferation and impair tumor suppression. Dysbiosis of the gut microbiome and alterations in bile acid metabolism generate carcinogenic metabolites that contribute to DNA damage and immune evasion. Additionally, obesity-induced tissue hypoxia fosters tumor growth through HIF-1α-mediated pathways. We further highlight organ-specific associations, such as visceral adiposity’s role in Barrett’s esophagus and hepatocellular carcinoma emerging from metabolic dysfunction-associated steatotic liver disease (MASLD). Importantly, emerging data suggest that weight loss, achieved via lifestyle, pharmacologic, or surgical interventions, may mitigate these carcinogenic pathways and improve tumor biology. As obesity prevalence continues to rise globally, elucidating its mechanistic ties to GI malignancies is essential for risk stratification, prevention strategies, and personalized care. By integrating epidemiologic and molecular insights, this review underscores the need for multidisciplinary approaches to curb the oncogenic burden of obesity and improve outcomes in GI oncology.